Professor Riste?rd ? Laoide:

This has to be done in a very structured and evidence-based manner. That was how it was originally done for breast screening. It involved international best practice and an evidence-based manner to ensure that we produced a quality screening programme with appropriate metrics and a reduction in mortality for patients.

The UK is rolling out programmes, which it is calling screening programmes even though they are more akin to the lung health we are now talking about. They have rolled out these programmes as pilots and are selecting different locations. There is an appetite among clinicians in this country to do this. The governance of it is through the national screening advisory group in the Department of Health. I suspect it would be very interested in the results of a pilot programme in this country.